These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 965791)

  • 1. Bartter's syndrome: a metabolic study.
    Ross D; Weber HP
    J Kans Med Soc; 1976 Sep; 77(9):378-82. PubMed ID: 965791
    [No Abstract]   [Full Text] [Related]  

  • 2. Aldosterone and other mineralocorticoids in Bartter's syndrome.
    Saruta T; Fujimaki M; Senba S; Saito I; Konishi K
    J Lab Clin Med; 1984 Jun; 103(6):848-53. PubMed ID: 6373989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bartter's syndrome--a case study with special reference to the role of renal prostaglandins and the renin-angiotensin-aldosterone system].
    Sato M; Abe K; Hoshima M; Chiba S; Ritsu K
    Horumon To Rinsho; 1979 Jan; 27(1):51-7. PubMed ID: 428121
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacologic studies in Bartter's syndrome: opposite effects of treatment with antikaliuretic and antiprostaglandin drugs. Part I.
    Simatupang TA; Radó JP; Boer P; Geyskes GG; Vos J; Dorhout Mees EJ
    Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):14-8. PubMed ID: 631965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandins, potassium, and Bartter's syndrome.
    Ferris TF
    J Lab Clin Med; 1978 Nov; 92(5):663-8. PubMed ID: 361914
    [No Abstract]   [Full Text] [Related]  

  • 6. Some aspects of urinary kallikrein in a patient with Bartter's syndrome.
    Tamura Y; Matsuda Y; Yamada K; Takagi T; Nishikawa T; Watanabe M; Mikami K; Moriya H; Kumagai A
    Adv Exp Med Biol; 1979; 120B():515-24. PubMed ID: 517245
    [No Abstract]   [Full Text] [Related]  

  • 7. Functional interpretation of the kidney juxtaglomerular apparatus using renin immunohistochemistry in Bartter's, pseudo-Bartter's and Conn's syndromes.
    Lertprasertsuke N; Kakudo K; Osamura Y; Nomoto Y; Sakai H; Watanabe K
    Tokai J Exp Clin Med; 1990 Jul; 15(4):317-26. PubMed ID: 2130539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Variations in renin and aldosterone activity in a typical case of Barter syndrome. Influence of anti-aldosterones and sodium intake].
    Zech P; Pozet N; Sassard J; Leitienne P; Blanc N; Colon S; Berthoux F; Touraine JL; Traeger J
    J Urol Nephrol (Paris); 1974 Sep; 80(9):760-5. PubMed ID: 4463254
    [No Abstract]   [Full Text] [Related]  

  • 9. [Plasma and urinary prostaglandins in Bartter's and pseudo-Bartter's syndrome (author's transl)].
    Hornych A
    Nephrologie; 1980; 1(3):113-6. PubMed ID: 6945487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of chloride transport in the thick ascending limb in the pathogenesis of Bartter's syndrome.
    Gill JR
    Klin Wochenschr; 1982 Oct; 60(19):1212-4. PubMed ID: 6755050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bartter's syndrome].
    Tomita K; Shinohara S; Mito Y; Tomiyama O; Shiigai T; Kitaoka T
    Nihon Rinsho; 1979; 37(2):362-9. PubMed ID: 439425
    [No Abstract]   [Full Text] [Related]  

  • 12. Systemic prostaglandin I2 synthesis is normal in patients with Bartter's syndrome.
    Watson ML; Gill JR; Branch RA; Oates JA; Brash AR
    Lancet; 1983 Aug; 2(8346):368-70. PubMed ID: 6135873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bartter's syndrome: seven cases in siblings. Hypothesis of mild forms (author's transl)].
    Nivet H; Rolland JC; Lebranchu Y; Dray F; Benatre A; Drucker J; Grenier B; Bagros P
    Nouv Presse Med; 1980 Apr; 9(18):1287-90. PubMed ID: 6990383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bartter's syndrome.
    Chan JC; Cooper SM
    Int J Pediatr Nephrol; 1981 Mar; 2(1):47-52. PubMed ID: 7037669
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal tubular reabsorption of chloride in Bartter's syndrome and other conditions with hypokalemia.
    Rodriguez Portales JA; Delea CS
    Clin Nephrol; 1986 Dec; 26(6):269-72. PubMed ID: 3802593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of indomethacin on urinary kallikrein excretion in Bartter's syndrome of the adult.
    Lechi A; Mantero F; Opocher G; Armanini D; Lechi C; Covi G
    J Endocrinol Invest; 1981; 4(1):17-20. PubMed ID: 7016967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bartter's syndrome: effect of indomethacin on prostaglandins, urinary kallikrein, renin-angiotensin-aldosterone system, and the response to angiotensin II antagonist.
    Sasaki H; Kawasaki T; Okumura M; Asano T; Abe K; Arakawa K
    Endocrinol Jpn; 1980 Aug; 27(4):417-29. PubMed ID: 7007031
    [No Abstract]   [Full Text] [Related]  

  • 18. [Value and limitations of indomethacin in the treatment of Bartter's syndrome].
    Dequiedt P; Lefebvre J; Raviart B; Vanhille P; Lepoutre E; Lelièvre G; Tacquet A
    J Urol Nephrol (Paris); 1977 Sep; 83(9):688-93. PubMed ID: 926230
    [No Abstract]   [Full Text] [Related]  

  • 19. On the pathogenetic role of prostaglandins in Bartter's syndrome.
    Nielsen I; Hesse B; Christensen P
    Acta Med Scand Suppl; 1979; 625():135-40. PubMed ID: 285569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the pathogenesis of Bartter's syndrome: report of studies in a patient with this disorder.
    Norby L; Mark AL; Kaloyanides GJ
    Clin Nephrol; 1976 Sep; 6(3):404-13. PubMed ID: 991467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.